Carlos Brito Archives - CDR – Chain Drug Review

AB InBev, SABMiller strike deal to merge

November 11, 2015 by Chain Drug Review Alan Clark, Anheuser-Busch InBev, Carlos Brito, Jan du Plessis, Mark Hunter, MillerCoors, Molson Coors Brewing Co., SABMiller, U.S. beer market Business, Leading Headlines, Supplier News

NEW YORK — Beer giants Anheuser-Busch InBev has reached an agreement to acquire SABMiller plc in a deal valued at about $108 billion. Clearing the way for the agreement was a deal for SABMiller to sell its 58% stake in its MillerCoors LLC joint venture to partner Molson Coors Brewing Co. for $12 billion. SABMiller’s

Anheuser-Busch InBev’s latest bid nixed by SABMiller

October 7, 2015 by Chain Drug Review Anheuser-Busch InBev, Carlos Brito, global beer market, Jan du Plessis, SABMiller Business, Supplier News

BRUSSELS, Belgium — Beer giant Anheuser-Busch InBev has offered to buy fellow brewing behemoth SABMiller plc for $104 billion (U.S.) but saw its increased bid quickly rejected. AB InBev said Wednesday that it’s now offering £42.15 ($64.60) per share for SABMiller, a 44% premium from the latter’s closing share price of £29.34 ($44.97) on Sept.